Mechanism of double exposure strategy for improving down-skin roughness and dimensional accuracy in support-free printing by Ting Zhang, Xin zhou, Dianzheng Wang, Zhibin An, Guoquan Ding, Hanyu Gao, Dongliang Bian

Get full text

Neoadjuvant camrelizumab plus chemotherapy or apatinib for resectable stage IIA–IIIA NSCLC: a multicenter, two-arm, phase II exploratory trial by Shuyu Ji, Zhenxin Sheng, Dongliang Bian, Minwei Bao, Kaiqi Jin, Wentian Zhang, Xinsheng Zhu, Fenghuan Sun, Haoran Xia, Han Zhang, Ziyun Shen, Huansha Yu, Lele Zhang, Jie Huang, Zhang Peng, Nan Song, Haifeng Wang, Biyun Qian, Yuming Zhu

Get full text

Anti-PD1 based precision induction therapy in unresectable stage III non-small cell lung cancer: a phase II umbrella clinical trial by Chengxiang Yi, Dongliang Bian, Jue Wang, Shiqi Hu, Liangdong Sun, Yilv Yan, Suyu Wang, Ziyun Shen, Huansha Yu, Yong Yang, Yirui Zhou, Xiaogang Liu, Nan Song, Yuming Zhu, Deping Zhao, Gening Jiang, Liang Duan, Wenxin He, Dong Xie, Jie Dai, Lele Zhang, Peng Zhang

Get full text

Neoadjuvant Aumolertinib for unresectable stage III EGFR-mutant non-small cell lung cancer: a single-arm phase II trial by Dongliang Bian, Shuyu Ji, Yue Liu, Zhida Huang, Lei Jiang, Ming Liu, Xiao Bao, Jie Yang, Yirui Zhou, Junjie Hu, Liangdong Sun, Yingzhi Zheng, Jie Huang, Jing Liu, Xinsheng Zhu, Jing Zhang, Lele Zhang, Xiaogang Liu, Wenxin He, Dong Xie, Yuming Zhu, Chunyan Wu, Deping Zhao, Liang Duan, Gening Jiang, Peng Zhang

Get full text